• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心绞痛症状始终能够预测冠心病门诊患者的总死亡率。

Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease.

作者信息

Mozaffarian Dariush, Bryson Chris L, Spertus John A, McDonell Mary B, Fihn Stephan D

机构信息

Health Services Research & Development Center of Excellence, Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle, Wash, USA.

出版信息

Am Heart J. 2003 Dec;146(6):1015-22. doi: 10.1016/S0002-8703(03)00436-8.

DOI:10.1016/S0002-8703(03)00436-8
PMID:14660993
Abstract

BACKGROUND

Age, race, education, and diabetes have been associated with differences in anginal symptoms, treatments, and outcomes among outpatients with coronary artery disease (CAD), but there is little data on whether such characteristics affect relationships between anginal symptoms and mortality.

METHODS

Using a prospective cohort design, we examined associations of anginal symptoms, as assessed by the Seattle Angina Questionnaire, with total mortality among 8908 outpatients with CAD to investigate whether this relationship is influenced by patient demographic or clinical characteristics. Potential effect modification was primarily assessed for age, race, education, and diabetes, and secondarily assessed for smoking, prevalent congestive heart failure (CHF), myocardial infarction, and coronary revascularization.

RESULTS

Over 2 years mean follow-up, there were 896 deaths. After adjustment for potential confounders, persons reporting greater physical limitation due to angina had higher mortality: 27% higher with mild limitation (hazard ratio [HR] 1.27, 95% CI 0.98-1.64), 61% higher with moderate limitation (HR 1.61, 95% CI 1.27-2.05), and 2.5-fold higher with the greatest limitation (HR 2.55, 95% CI 1.97-3.30), compared with little or no limitation (P for trend <.001). Anginal instability was also independently predictive of mortality. There was little evidence that these relationships varied by age, race, education, diabetes, smoking, or presence of CHF, prior myocardial infarction, or prior coronary revascularization (P for each interaction >.28). Anginal symptoms predicted higher mortality risk comparable to a decade of age difference, presence of diabetes, or presence of CHF.

CONCLUSIONS

Among outpatients with CAD, self-reported anginal symptoms consistently predict mortality irrespective of differences in age, race, education, or clinical comorbidities.

摘要

背景

年龄、种族、教育程度和糖尿病与冠心病(CAD)门诊患者的心绞痛症状、治疗及预后差异有关,但关于这些特征是否影响心绞痛症状与死亡率之间的关系,数据较少。

方法

采用前瞻性队列设计,我们通过西雅图心绞痛问卷评估了8908例CAD门诊患者的心绞痛症状与总死亡率之间的关联,以研究这种关系是否受患者人口统计学或临床特征的影响。主要评估了年龄、种族、教育程度和糖尿病对潜在效应的修正作用,次要评估了吸烟、既往充血性心力衰竭(CHF)、心肌梗死和冠状动脉血运重建对潜在效应的修正作用。

结果

在平均2年的随访期内,有896例死亡。在调整潜在混杂因素后,因心绞痛报告身体限制更大的患者死亡率更高:与几乎没有或没有限制相比,轻度限制患者死亡率高27%(风险比[HR]1.27,95%置信区间0.98 - 1.64),中度限制患者死亡率高61%(HR 1.61,95%置信区间1.27 - 2.05),最大限制患者死亡率高2.5倍(HR 2.55,95%置信区间1.97 - 3.30)(趋势P值<.001)。心绞痛不稳定性也是死亡率的独立预测因素。几乎没有证据表明这些关系因年龄、种族、教育程度、糖尿病、吸烟或CHF、既往心肌梗死或既往冠状动脉血运重建的存在而有所不同(各交互作用P值>.28)。心绞痛症状预测的较高死亡风险与相差十岁、患有糖尿病或患有CHF相当。

结论

在CAD门诊患者中,无论年龄、种族、教育程度或临床合并症存在何种差异,自我报告的心绞痛症状始终可预测死亡率。

相似文献

1
Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease.心绞痛症状始终能够预测冠心病门诊患者的总死亡率。
Am Heart J. 2003 Dec;146(6):1015-22. doi: 10.1016/S0002-8703(03)00436-8.
2
Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry.稳定性冠心病门诊患者心绞痛症状和心肌缺血的患病率及其对临床结局的影响:来自国际观察性 CLARIFY 登记研究的数据。
JAMA Intern Med. 2014 Oct;174(10):1651-9. doi: 10.1001/jamainternmed.2014.3773.
3
Angina symptoms are associated with mortality in older women with ischemic heart disease.心绞痛症状与老年缺血性心脏病女性患者的死亡率相关。
Circulation. 2009 Dec 8;120(23):2330-6. doi: 10.1161/CIRCULATIONAHA.109.887380. Epub 2009 Nov 23.
4
Long-term outcomes of optimized medical management of outpatients with stable coronary artery disease.稳定型冠状动脉疾病门诊患者优化药物治疗的长期结局
Am J Cardiol. 2004 Feb 1;93(3):294-9. doi: 10.1016/j.amjcard.2003.10.007.
5
Residual high-grade angina after enhanced external counterpulsation therapy.增强型体外反搏治疗后残留的重度心绞痛
Cardiovasc Revasc Med. 2007 Jul-Sep;8(3):161-5. doi: 10.1016/j.carrev.2006.12.003.
6
Usefulness of self-reported leisure-time physical activity to predict long-term survival in patients with coronary heart disease.自我报告的休闲时间身体活动对预测冠心病患者长期生存的有用性。
Am J Cardiol. 2008 Aug 15;102(4):375-9. doi: 10.1016/j.amjcard.2008.03.072. Epub 2008 May 22.
7
Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.老年人未来致命性与非致命性冠心病事件的特征及基线临床预测因素:心血管健康研究
Circulation. 2006 May 9;113(18):2177-85. doi: 10.1161/CIRCULATIONAHA.105.610352. Epub 2006 May 1.
8
Long-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery disease.经医学治疗的心绞痛和多支血管病变患者的长期发病率和死亡率。
Am Heart J. 2009 Dec;158(6):933-40. doi: 10.1016/j.ahj.2009.10.013.
9
Is immigration associated with an increase in risk factors and mortality among coronary artery disease patients? A cohort study of 13,742 patients.移民是否与冠状动脉疾病患者的危险因素增加及死亡率上升有关?一项针对13742名患者的队列研究。
Isr Med Assoc J. 2002 May;4(5):326-30.
10
Prognostic importance of presenting symptoms in patients undergoing exercise testing for evaluation of known or suspected coronary disease.在接受运动测试以评估已知或疑似冠心病的患者中,就诊症状的预后重要性。
Am J Med. 2004 Sep 15;117(6):380-9. doi: 10.1016/j.amjmed.2004.06.004.

引用本文的文献

1
The Pullback Pressure Gradient: A Physiologic Index to Differentiate Focal From Diffuse Coronary Artery Disease.回撤压力梯度:区分局灶性与弥漫性冠状动脉疾病的生理学指标。
JACC Adv. 2025 Mar 26;4(5):101679. doi: 10.1016/j.jacadv.2025.101679.
2
Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial.利用来自缺血性心脏病优化药物治疗与血管重建比较有效性研究(ISCHEMIA试验)的随机数据评估稳定型缺血性心脏病冠状动脉血运重建的适宜使用标准。
Circ Cardiovasc Qual Outcomes. 2025 Mar;18(3):e010849. doi: 10.1161/CIRCOUTCOMES.124.010849. Epub 2025 Feb 26.
3
Pullback Pressure Gradient-An Emerging Concept in Patients with Coronary Artery Disease.
回撤压力梯度——冠状动脉疾病患者中的一个新兴概念
Rev Cardiovasc Med. 2024 Aug 7;25(8):278. doi: 10.31083/j.rcm2508278. eCollection 2024 Aug.
4
Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial.赞布特坦治疗微血管性心绞痛的随机、安慰剂对照、交叉试验。
Circulation. 2024 Nov 19;150(21):1671-1683. doi: 10.1161/CIRCULATIONAHA.124.069901. Epub 2024 Sep 1.
5
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease.复杂冠状动脉疾病经皮冠状动脉介入治疗或冠状动脉旁路移植术后残余心绞痛对长期临床结局的影响。
Eur Heart J Qual Care Clin Outcomes. 2023 Aug 7;9(5):490-501. doi: 10.1093/ehjqcco/qcac052.
6
International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY Study.国际慢性稳定性心绞痛的演变和结局的观察性分析:多国 CLARIFY 研究。
Circulation. 2021 Aug 17;144(7):512-523. doi: 10.1161/CIRCULATIONAHA.121.054567. Epub 2021 Jul 15.
7
Prevalence of Angina Among Primary Care Patients With Coronary Artery Disease.冠心病初级保健患者心绞痛的患病率。
JAMA Netw Open. 2021 Jun 1;4(6):e2112800. doi: 10.1001/jamanetworkopen.2021.12800.
8
Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial.医学研究委员会精准医学联合赞布特坦治疗微血管心绞痛(PRIZE)试验的原理和设计。
Am Heart J. 2020 Nov;229:70-80. doi: 10.1016/j.ahj.2020.07.007. Epub 2020 Jul 17.
9
Effectiveness of Trimetazidine in Patients with Stable Angina Pectoris of Various Durations: Results from ODA.曲美他嗪对不同病程稳定型心绞痛患者的疗效:ODA研究结果
Cardiol Ther. 2020 Dec;9(2):395-408. doi: 10.1007/s40119-020-00174-7. Epub 2020 May 19.
10
Scoring System for Identification of "Survival Advantage" after Successful Percutaneous Coronary Intervention in Patients with Chronic Total Occlusion.慢性完全闭塞患者经皮冠状动脉介入治疗成功后“生存优势”识别评分系统
J Clin Med. 2020 May 2;9(5):1319. doi: 10.3390/jcm9051319.